JOHN R STROEHLEIN to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications JOHN R STROEHLEIN has written about TOR Serine-Threonine Kinases.
Connection Strength
0.075
-
Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer. Int J Oncol. 2014 Aug; 45(2):567-74.
Score: 0.075
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.